Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

NSE:SUNPHARMA Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	616,309	584,620	525,784	484,969	438,857	386,545
Revenue Growth	12.13%	11.19%	8.42%	10.51%	13.53%	15.39%
Gross Profit Gross Profit Growth	488,899	459,834	410,200	370,547	325,670	277,784
Operating Income Operating Income Growth	143,365	136,116	126,055	105,202	93,058	81,560
Net Income Net Income Growth	109,662	114,794	109,290	95,764	84,736	32,727
Earnings Per Share EPS Growth	45.71	47.80	45.55	39.90	35.30	13.60
EPS Growth	4.95%	4.94%	14.16%	13.03%	159.56%	12.40%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India Formulations India Formulations Growth	208,616	192,904	169,230	148,893	136,031	127,593
US Formulations US Formulations Growth	168,392	168,242	162,403	153,493	135,353	113,737
Emerging Markets Emerging Markets Growth	120,825	111,865	94,160	86,195	78,977	67,432
Rest of the World Formulations Rest of the World Formulations Growth	90,259	85,684	71,626	67,128	60,426	54,545
Active Pharmaceutical Ingredients (API) Active Pharmaceutical Ingredients (API) Growth	23,011	21,853	21,292	19,187	19,724	18,354
Other Segment Other Segment Growth	2,020	1,654	1,702	2,690	2,279	2,604
Other Operating Other Operating Growth	3,185	2,419	5,372	7,384	6,068	2,281

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	335,701	335,166	261,227	190,901	151,300	126,548
Total Debt Total Debt Growth	32,413	46,273	23,622	32,737	68,859	12,903
Net Cash (Debt) Net Cash Growth	303,288	288,893	237,605	158,164	82,441	113,645
Net Cash Growth	33.81%	21.58%	50.23%	91.85%	-27.46%	99.57%
Net Cash Per Share Net Cash Per Share Growth	126.53	120.41	99.03	65.92	34.36	47.37

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	107,795	124,192	140,721	121,350	49,593	89,845
Capital Expenditures CapEx Growth	-30,060	-36,094	-21,286	-22,018	-20,856	-14,950
Free Cash Flow Free Cash Flow Growth	77,735	88,098	119,435	99,332	28,738	74,895
Free Cash Flow Growth	-11.00%	-26.24%	20.24%	245.65%	-61.63%	49.78%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	79.33%	78.66%	78.02%	76.41%	74.21%	71.86%
Operating Margin	23.26%	23.28%	23.97%	21.69%	21.20%	21.10%
Pretax Margin	24.32%	25.77%	26.13%	22.78%	21.33%	11.55%
Profit Margin	17.79%	19.64%	20.79%	19.75%	19.31%	8.47%
FCF Margin	12.61%	15.07%	22.72%	20.48%	6.55%	19.38%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	16.000	16.000	16.000	13.500	11.500	10.000
Dividend Per Share Growth	0%	0%	18.52%	17.39%	15.00%	33.33%
Dividend Yield	0.90%	0.91%	0.92%	0.83%	1.17%	1.09%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	38.80	36.73	38.08	40.60	27.84	67.06
Forward PE	30.53	34.42	35.80	42.36	28.97	28.54
P/FCF Ratio	54.74	47.86	34.85	39.14	82.08	29.30
PS Ratio	6.90	7.21	7.92	8.02	5.38	5.68

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error